NIREUSAQUACULTURES.A. Mainevents12M2013 - - PowerPoint PPT Presentation
NIREUSAQUACULTURES.A. Mainevents12M2013 - - PowerPoint PPT Presentation
AthensGreece|31March2014 12Months2013ResultsPresentation NIREUSAQUACULTURES.A. Mainevents12M2013
2
- !"#$ %
- &'(
- )(** $ '$
- € 30mi.fromlowerfishsalesprices– fromwhich€ 10mi.correspondto
lowerfishsalesvalue&€ 20mi.tolowervaluationofbiomass
- € 3mi.fromhigheraveragerawmaterialpricesforfishfeed
- € 24mi.fromlowerthanexpectedgrowthofthebiologicalassets
- € 11.3 mi.one offprovisionsoffromwhich€ 6.4foraffiliates chargedto
financialexpensesand€ 4.9mi.forcustomers
- additionaldeferredtaxes€ 2.7mi.fromtheincreaseofthecorporatetax
rateto26%
Mainevents12M2013
Keypoints
3
Bass&bream– ExportpricetoItaly&Spain
Source:Kontalianalyse“Seabass&SeabreamFeb2014monthlyreport”
- ExternalFactors
4
Industrysupplydevelopment
Externalfactors
Theexpectedproductionof seabassandseabreamin 2013,versus2012,was:
- atslightlyhigherlevels
- withdeclininggrowth
Pricesweremostlyaffected bytheliquidityneedsofthe sector
5
SalesbyBusinessSector
! + ",-"% . /+ 001&/2 3
Salesoffishfarmingdown € 6.1mi.fromdeclineinaverageweightedprice&reduced juvenilessales– fishvolumesup+4% Feedsalesup+€ 3.4mi. Salesofaviculture,animalcultureproducts&equipmentdown€ 0.9mi Salesevolution Salesbysectorfor12M2013 (%distribution)
6
ExportsEvolution
Salesevolution
in€ 45404 4540% Greece 46.57 44.38 EU 122.24 122.26 Other 33.34 31.95
- Εxports
Domesticsales
Exports&domesticsalesdistribution(%)
Exportsshareto78%oftotalsales
7
BalanceSheet
Financials Endofperiod biologicalassets valuelower€ 70mi. from:
- lowerfishprices
- lowerthan
expectedgrowth
Assets
inmi.€
12M2013 12M2012 66&3 7# 7
- %07((
%07(( 8$ (070 *%7( /$ 7# *7( TotalnonCcurrent 204,23 189,50 8 0070 74 9 07(# 7% : #7% *#7 / #7( 447% ;23 7# (7 Totalcurrent 184,50 280,91 Totalassets 388,73 470,40
Equityandliabilities
inmi.€
12M2013 12M2012 <=3 #7* #47( )$
- 70.
- *740.
- Totalshareholders'equity
andnonCcontrolling interests 57,69 137,67 >?@ %7%0 *7% A ' *7(% 70# /$ 47*% 7*# TotalnonCcurrentliabilities 56,57 112,97 2 74% 47*# ;@ %7*# %74 / 7(0 *7 Totalcurrentliabilities 274,48 219,76 Totalliabilities 331,05 332,74 Totalequityandliabilities 388,73 470,40
8
IncomeStatement
Netresultsimpactedby:
- € 30from lowerpricing
- € 24 mi.fromlowerthan
expectedbiomassgrowth
- € 3mi.fromhigherraw
materialscostforfishfeed
- OneCoffprovisionsof€ 11.3
mi.fromwhich€ 6.4mi.for affiliatesand€ 4.9mi.for customers
- € 2.7additionaldeferredtax
fromtheincreaseofcorporate taxrate Financials
- 12M2013
12M2012 8< 149,47 158,92 )$8< 49,11 43,24 TotalSales 198,58 202,16 Effectofmeasurementofbiological assetsatfairvalue(*) (71,27)
- (11,51)
- :
- 0(7#%.
- 0#7.
- <2'
- %07*.
- %7*4.
- %
- 7.
- 4#7#0.
- /'
- %74.
- 470.
- /
474
- %70
- EBITDAbeforebiologicaladjustment
(13,80)
- 20,99
- 8,
- #7%.
- #74(.
- EBITDAafterbiologicaladjustment
(60,17)
- 6,73
- Earnings/(loss)beforeinterest
andtaxes(EBIT) (67,74)
- (2,24)
- Earnings/(loss)beforetaxes(EBT)
(87,43)
- (16,17)
- '
7*
- 474(
- Earnings/(loss)aftertaxes(EAT)
(75,48)
- (13,89)
- &3
- (*70(.
- #70*.
- )$
- 07#.
- 07
- &-.
- 7(.
- 07440.
- B.3-"$.
?- .9!:<
9
CashFlowStatement
Financials
PositiveCFO€ 7.19 mi. Increasednetinvestments
- Newpackagingplantin
WesternGreecetargetingcost reduction
- 12M2013
12M2012 6 '
- (7#%.
- 7(.
- A
74
- 7(%
- 5
4#7%
- #7%
- !,
#7%(
- #74*
- :?-.
447*
- 7#0.
- :?-.
- 4744.
- %7.
- :.? 2
- 470#
- 70#
- 9'
- 7#4.
- %7(#.
- '
- 074#.
- 07((.
- Cashflowfromoperatingactivities
7,19
- 14,16
- )-9.?A
- 7*.
- *7*.
- FCFFreecashflowafteroperations
andinvestments 0,33
- 8,60
- :
0740
- 07%#
- Cashflowfrominvestingactivities
(6,66)
- (5,22)
- Cashflowfromfinancingactivities
1,22
- (14,08)
- Totalcashflowreportingperiod
1,75
- (5,15)
- ;3
%70
- 7
- !',
- 7#.
- 070#
- Cashandcashequivalentsatthe
endoftheperiod 3,62
- 3,01
10
- FeedConsumptionandJuvenilesInput
Outlook
11
Bass&bream– Weeklypricedevelopment2014
Source:Kontalianalyse“Seabass&SeabreamFeb2014monthlyreport” Mercamadridpricesarewholesaleandindicativeofthepricetrend– actualfishpricesvarybysizeandmarket
- ExternalFactors
12
Appendix:Costdynamicsinfishfarming
HarvestWeight
NormalOperations Operations+Disease+Mortality Operations+Disease
Costperkg
cost Mortality cost Disease cost Weight
C@ disease 0$,$ mortality
Appendix
13
Appendix:IAS41forbiologicalassets
! 3 $ , -9!:<%2 9D<#.
- @.
'@ , @ @ $ $ 8< $ <9<$ 8 , -. )$ ?,7 737
- .7
E biomassatbeginningofperiod (+)purchasesofbiologicalassetsforproduction ( )biomassatendofperiod =effectofmeasurementofbiomassatfairvalue
Fairvalueof biomass(B.S.)
VolumexPrice
KeyDrivers
MVolume M Price
BiologicalSales (I.S.)
Thesalesoffish& juvenilesproduced– to includeprocessedfish
NonCbiological sales(I.S.)
Thesalesoffish& juvenilesproducedby
- thers,fishfeed,nets,
- therproducts
TotalSales (I.S.)
Biologicalsales+ NonCbiologicalsales
Effectof measurement
- fbiomassat
fairvalue
TheinterCperiod differenceinthefair biomassvalue Appendix
14
Communication– FinancialCalendar
InvestorRelations
Ms.MariaKotsovou,IRManager "%040%%* 5"%0%%%* &@F
FinancialCalendar2014
12M2013Results Monday,31March2014 %540#:E !7%0540# /D5E 57%0G40# 540#:E !74D40# 540#:E !74)40#
Legal Notice
This presentation has been prepared solely for informational purposes. Any projections or other estimates in this presentation, including estimates of returns or performance, comments with respect to our objectives and strategies, or the results
- f our operations and business, are forwardClooking statements based upon certain
assumptions that may be wrong. These assumptions may be influenced by factors within or beyond our control, and actual results may differ materially from any estimates and projections. Factors influencing actual results include but are not limited to fluctuations in fish prices and raw material prices, the effects
- f
competition in the areas in which we operate, changes in the economic environment, regulatory and economic conditions. This presentation is not an offer to buy or sell
- r a solicitation of an offer to buy or sell any security or instrument or to participate
in any trading strategy. No part
- f
this presentation may be construed as constituting investment advice or a recommendation to enter into any transaction. No representation or warranty is given with respect to the accuracy or completeness
- f the information contained in this presentation, and no claim is made that any
future offer to transact any securities will conform to any terms that may be contained herein. Before entering into any transaction, investors should determine any economic risks and benefits, as well as any legal, tax and accounting consequences of doing so, as well as their ability to assume such risks, without reliance on the information contained in this presentation.
Appendix